At yesterday´s BII & Science Prize for Innovation event, which recognizes and celebrates bold researchers internationally and presented winner Aditya Kunjapur Assistant Professor & Entrepreneur from University of Delaware, MVA member BioInnovation Institute (BII) and Science also announced launch the BII & Science Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine.
The introduction of the Translational Medicine Prize for Innovations in Women´s Health and Gender Medicine recognizes researchers who have developed innovative advances with translational potential to impact women’s health and gender medicine globally.
Contributions within any area of women’s health and gender medicine will be considered, including maternal health and chronic gynecological diseases, reproductive health including female and male contraception and infertility, or elucidation of sex- and gender-specific approaches to conditions that affect women differently or disproportionately. The winner will have their essay published in the Journal, Science Translational Medicine, and will receive a cash reward of $25,000 to further progress their research.
“We are proud to introduce this Prize alongside Science Journals, following the success of our Innovation Prize. Women’s Health remains a core focus for BII, and we continue to support early-stage start-ups and projects in the field, through programmes such as our collaboration with Ferring Pharmaceuticals. We hope this award, which will be announced in 2025, provides the well-deserved recognition of the researchers leading the way in this underserved area of research.” said Jens Nielsen, Chief Executive Officer of BII.
Learn more at BII.dk